Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Patients with surgically altered anatomy receiving Motorized Spiral Eneroscopy (MSE)-assisted ERCP at a single endoscopic reference center for various indications are planned to be retrospectively enrolled
All consecutive patients with altered upper gastrointestinal anatomy after Billroth-II- or Roux-en-Y reconstructive surgery and indication for ERCP with biliary and/or pancreatic indication, who underwent routine Enteroscopy-assisted ERCP using MSE, at the study center during the study period, will be enrolled in the analysis.
Primary endpoint of the study will be efficacy and safety of MSE-assisted ERCP.
Retrospective epidemiologic Study (not interventional) was approved by local IRB and ethical committee of the North-Rhine Chamber of Physicians (Düsseldorf, Germany), Reference Number: 177/2021.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| MSE-ERCP | Group of patients, that received motorized spiral enteroscopy assisted ERCP in altered anatomy at the single study center |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| MSE-ERCP | Device | No interventional study, MSE-ERCP performed within routine treatment, (approved indication of device) |
|
| Measure | Description | Time Frame |
|---|---|---|
| Success rate of MSE-ERCP | rate of subjects with successfull MSE-assisted ERCP | intraprocedural |
| Adverse event rate of MSE-ERCP | rate of adverse events during and early after MSE-ERCP | 3 days |
| Measure | Description | Time Frame |
|---|---|---|
| Success rate of enteroscopy | rate of subjects with successful enteroscopic access to the papilla | intraprocedural |
| Procedural duration | overall time for MSE-ERCP (scope in to scope out) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
- due to the retrospective design of the study, no exclusion criteria are defined
Not provided
Not provided
Not provided
Patients with surgically altered upper gastrointestinal anatomy and indication for endoscopic retrograde cholangio-pancreatography
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Torsten Beyna, MD PhD | Contact | 00492119191605 | torsten.beyna@evk-duesseldorf.de | |
| Markus Schneider, MD | Contact | 00492119191605 | markus.schneider@evk-duesseldorf.de |
| Name | Affiliation | Role |
|---|---|---|
| Torsten Beyna, MD PhD | Evangelisches Krankenhaus Düsseldorf, Department of Gastroenterology and Therapeutic Endoscopy | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Evangelisches Krankenhaus | Düsseldorf | 40217 | Germany |
No exchange of individual data is planned
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| intraprocedural |